Literature DB >> 4102606

Further observations on the effect of synthetic thyrotropin-releasing hormone in man.

B J Ormston, J R Kilborn, R Garry, J Amos, R Hall.   

Abstract

Synthetic thyrotrophin-releasing hormone (TRH) given intravenously in doses of 50 mug or more causes a significant rise in serum thyroid-stimulating hormone (TSH) levels but has no effect on serum growth hormone, plasma luteinizing hormone, or plasma 11-hydroxycorticosteroids under carefully controlled basal conditions.The peak TSH response to intravenous TRH occurs at 20 minutes. The mild and transient side effects, which occur only after intravenous TRH, include nausea, a flushing sensation, a desire to micturate, a peculiar taste, and tightness in the chest. There is considerable variability in response to a given dose of TRH in the same subject on different occasions and in different subjects. Oral administration of TRH in doses of 1 mg and above causes a rise in serum TSH, maximal at two hours, a consistent response being obtained at doses of 20 mg and above. A rise in serum protein-bound iodine (P.B.I.) follows that of TSH, a consistent response being observed at 40-mg doses of TRH orally. Measurements of serum TSH after intravenous administration of TRH or of serum TSH or serum P.B.I. after oral TRH should prove useful tests of pituitary TSH reserve.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4102606      PMCID: PMC1795339          DOI: 10.1136/bmj.2.5755.199

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  The diagnosis of hypopituitarism with special reference to the estimation of plasma non-esterified fatty acids.

Authors:  R Wilkinson; R Hall; A Cooper; D J Newell
Journal:  J Endocrinol       Date:  1970-02       Impact factor: 4.286

2.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

3.  [Action of proteolytic enzymes on purified preparations of the TSH-hypophysiotropic hypothalamic hormone, TRF].

Authors:  R Burgus; D N Ward; E Sakiz; R Guillemin
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1966-06-20

4.  [Synthetic polypeptide derivatives with TRF hypophysiotropic activity. New data].

Authors:  R Burgus; T F Dunn; D Desiderio; W Vale; R Guillemin
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1969-07-16

5.  Release of TSH by oral administration of synthetic peptide derivatives with TRF activity.

Authors:  W Vale; R Burgus; T F Dunn; R Guillemin
Journal:  J Clin Endocrinol Metab       Date:  1970-01       Impact factor: 5.958

6.  Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man.

Authors:  N Fleischer; R Burgus; W Vale; T Dunn; R Guillemin
Journal:  J Clin Endocrinol Metab       Date:  1970-07       Impact factor: 5.958

7.  The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide.

Authors:  J Boler; F Enzmann; K Folkers; C Y Bowers; A V Schally
Journal:  Biochem Biophys Res Commun       Date:  1969-11-06       Impact factor: 3.575

8.  Thyroid-stimulating hormone response to synthetic thyrotrophin releasing hormone in man.

Authors:  R Hall; J Amos; R Garry; R L Buxton
Journal:  Br Med J       Date:  1970-05-02

9.  Activity and specificity of synthetic thyrotropin-releasing hormone in man.

Authors:  C Y Bowers; A V Schally; D S Schalch; C Gual; A J Kastin; K Folkers
Journal:  Biochem Biophys Res Commun       Date:  1970-05-11       Impact factor: 3.575

10.  [Syntheses of thyrotropin-releasing hormones (TRH) (Schaf) and related peptides].

Authors:  D Gillessen; A M Felix; W Lergier; R O Studer
Journal:  Helv Chim Acta       Date:  1970       Impact factor: 2.164

View more
  12 in total

1.  Pressor effects of thyrotrophin releasing hormone during thyroid function testing.

Authors:  E Rosenthal; Y C Najm; M N Maisey; P V Curry
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-28

2.  Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitus.

Authors:  O Giampietro; M Ferdeghini; R Miccoli; G Gregori; G Penno; S Bertoli; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

3.  [Plasma cortisol levels following intravenous injection of thyreotropin releasing hormone (TRH) in man].

Authors:  H Bethge; W Wildmeister; F A Horster
Journal:  Klin Wochenschr       Date:  1972-02-15

4.  Thyrotropin releasing hormone and the lower oesophageal sphincter.

Authors:  W Melia; D O'Beirne; J F Finucane; J S Doyle
Journal:  Ir J Med Sci       Date:  1980-04       Impact factor: 1.568

5.  Hypothalamic releasing hormones.

Authors: 
Journal:  Br Med J       Date:  1972-01-08

6.  Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.

Authors:  P J Snyder; R D Utiger
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

7.  Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones.

Authors:  P J Snyder; R D Utiger
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

8.  [Prolactin and thyrotropin after stimulation by thyrotropin releasing hormone a study under long-term administration of oral contraceptives (author's transl)].

Authors:  O Bellmann; C Bröschen-Zywietz; K Fichte
Journal:  Arch Gynakol       Date:  1978-02-22

9.  Combined test for assessment of anterior pituitary function.

Authors:  P Harsoulis; J C Marshall; S F Kuku; C W Burke; D R London; T R Fraser
Journal:  Br Med J       Date:  1973-11-10

10.  A combined anterior pituitary stimulation test: experience with 285 individuals.

Authors:  A N Elias; L J Valenta
Journal:  J Natl Med Assoc       Date:  1987-11       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.